These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 26843609

  • 21. Expression of myogenic regulatory factors and myo-endothelial remodeling in sporadic inclusion body myositis.
    Wanschitz JV, Dubourg O, Lacene E, Fischer MB, Höftberger R, Budka H, Romero NB, Eymard B, Herson S, Butler-Browne GS, Voit T, Benveniste O.
    Neuromuscul Disord; 2013 Jan; 23(1):75-83. PubMed ID: 23058947
    [Abstract] [Full Text] [Related]

  • 22. Platelet-endothelial cell adhesion molecule-1 and CD146: soluble levels and in situ expression of cellular adhesion molecules implicated in the cohesion of endothelial cells in idiopathic inflammatory myopathies.
    Figarella-Branger D, Schleinitz N, Boutière-Albanèse B, Camoin L, Bardin N, Guis S, Pouget J, Cognet C, Pellissier JF, Dignat-George F.
    J Rheumatol; 2006 Aug; 33(8):1623-30. PubMed ID: 16881117
    [Abstract] [Full Text] [Related]

  • 23. ANT1 is reduced in sporadic inclusion body myositis.
    Barca E, Aguennouz M, Mazzeo A, Messina S, Toscano A, Vita GL, Portaro S, Parisi D, Rodolico C.
    Neurol Sci; 2013 Feb; 34(2):217-24. PubMed ID: 22350218
    [Abstract] [Full Text] [Related]

  • 24. Gain and loss of extracellular molecules in sporadic inclusion body myositis and polymyositis--a proteomics-based study.
    Doppler K, Lindner A, Schütz W, Schütz M, Bornemann A.
    Brain Pathol; 2012 Jan; 22(1):32-40. PubMed ID: 21672074
    [Abstract] [Full Text] [Related]

  • 25. Sporadic inclusion body myositis: clinical, pathological, and genetic analysis of eight Polish patients.
    Kierdaszuk B, Berdynski M, Palczewski P, Golebiowski M, Zekanowski C, Kaminska AM.
    Folia Neuropathol; 2015 Jan; 53(4):355-66. PubMed ID: 26785370
    [Abstract] [Full Text] [Related]

  • 26. [Polymyositis, dermatomyositis and inclusion body myositis, nosological aspects].
    Eymard B.
    Presse Med; 2003 Oct 25; 32(35):1656-67. PubMed ID: 14631270
    [Abstract] [Full Text] [Related]

  • 27. The nonnecrotic invaded muscle fibers of polymyositis and sporadic inclusion body myositis: on the interplay of chemokines and stress proteins.
    De Paepe B, De Bleecker JL.
    Neurosci Lett; 2013 Feb 22; 535():18-23. PubMed ID: 23295907
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Immunolocalization of FAS and FAS ligand in inflammatory myopathies.
    De Bleecker JL, Meire VI, Van Walleghem IE, Groessens IM, Schröder JM.
    Acta Neuropathol; 2001 Jun 22; 101(6):572-8. PubMed ID: 11515785
    [Abstract] [Full Text] [Related]

  • 30. [Pathogenesis of primary inflammatory myopathies].
    Benveniste O, Squier W, Boyer O, Hilton-Jones D, Herson S.
    Presse Med; 2004 Nov 20; 33(20):1444-50. PubMed ID: 15611679
    [Abstract] [Full Text] [Related]

  • 31. Inclusion body myositis--a review.
    Vogel H.
    Adv Anat Pathol; 1998 May 20; 5(3):164-9. PubMed ID: 9868522
    [Abstract] [Full Text] [Related]

  • 32. Sporadic inclusion body myositis: possible pathogenesis inferred from biomarkers.
    Weihl CC, Pestronk A.
    Curr Opin Neurol; 2010 Oct 20; 23(5):482-8. PubMed ID: 20664349
    [Abstract] [Full Text] [Related]

  • 33. Differential diagnosis of vacuolar muscle biopsies: use of p62, LC3 and LAMP2 immunohistochemistry.
    Vittonatto E, Boschi S, CHIADò-Piat L, Ponzalino V, Bortolani S, Brusa C, Rainero I, Ricci F, Vercelli L, Mongini T.
    Acta Myol; 2017 Dec 20; 36(4):191-198. PubMed ID: 29770361
    [Abstract] [Full Text] [Related]

  • 34. [Histological data in inflammatory myositis].
    Mikol J, Polivka M.
    Ann Med Interne (Paris); 2001 Nov 20; 152(7):465-79. PubMed ID: 11965088
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Abnormalities of NBR1, a novel autophagy-associated protein, in muscle fibers of sporadic inclusion-body myositis.
    D'Agostino C, Nogalska A, Cacciottolo M, Engel WK, Askanas V.
    Acta Neuropathol; 2011 Nov 20; 122(5):627-36. PubMed ID: 21935636
    [Abstract] [Full Text] [Related]

  • 37. Inclusion body myositis with human immunodeficiency virus infection: four cases with clonal expansion of viral-specific T cells.
    Dalakas MC, Rakocevic G, Shatunov A, Goldfarb L, Raju R, Salajegheh M.
    Ann Neurol; 2007 May 20; 61(5):466-75. PubMed ID: 17366634
    [Abstract] [Full Text] [Related]

  • 38. Clinicopathologic features of myositis patients with CD8-MHC-1 complex pathology.
    Ikenaga C, Kubota A, Kadoya M, Taira K, Uchio N, Hida A, Maeda MH, Nagashima Y, Ishiura H, Kaida K, Goto J, Tsuji S, Shimizu J.
    Neurology; 2017 Sep 05; 89(10):1060-1068. PubMed ID: 28794251
    [Abstract] [Full Text] [Related]

  • 39. Upregulated inducible co-stimulator (ICOS) and ICOS-ligand in inclusion body myositis muscle: significance for CD8+ T cell cytotoxicity.
    Schmidt J, Rakocevic G, Raju R, Dalakas MC.
    Brain; 2004 May 05; 127(Pt 5):1182-90. PubMed ID: 15047591
    [Abstract] [Full Text] [Related]

  • 40. New developments in the role of cytokines and chemokines in inflammatory myopathies.
    Lundberg IE, Nyberg P.
    Curr Opin Rheumatol; 1998 Nov 05; 10(6):521-9. PubMed ID: 9812212
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.